Number of Shares
719,992.00
Current Holdings Value*
$29.15 Mil
% of Portfolio
5.96%
Total Estimate Gain
$30.82 Mil
% of Total Estimate Gain
130.48%

SILVERARC CAPITAL MANAGEMENT, LLC's Akero Therapeutics Inc Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 719,992.00 shares of Akero Therapeutics Inc(AKRO), totaling $29.15 Mil. This investment constitutes 5.96% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0.9% of the outstanding Akero Therapeutics Inc(AKRO) stock.

The initial trade took place in 2020Q4. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 10 purchases of AKRO, at an average price of $21.21, for a total of 1.11 Mil shares. In addition, there have been 5 sales at an average price of $43.01 for 393,699.00 shares. Based on historical transaction data and AKRO's current price of $52.08, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his AKRO holdings is $30.82 Mil, reflecting a 130.48% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC AKRO ($52.08) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC AKRO ($52.08) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1